Paper Details

  1. Home
  2. Paper Details

Comparative study of cimetidine and Mylanta II in the 6-week treatment of gastric ulcer.

Author: BaileyR J, FisherD, KirdeikisP, SherbaniukR W, ThomsonA B, WenselR H

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Cimetidine (300 mg q.i.d.) was more effective than antacids in healing gastric ulcers in 38 patients. Both treatments effectively relieved symptoms.
Paper Details　
Original Abstract of the Article :
The efficacy of antacid in the treatment of benign gastric ulcer is less well established than in the treatment of duodenal ulcer. The objective of this study was to monitor ulcer healing and symptom relief in 38 patients with gastric ulceration treated for 6 weeks with cimetidine (Tagamet) 300 mg q...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/00004836-198506000-00006

データ提供：米国国立医学図書館（NLM）

Comparing Cimetidine and Mylanta II for Gastric Ulcer Treatment

The field of gastroenterology is always searching for effective and safe treatments for digestive disorders. This study compares cimetidine, a histamine H2 receptor antagonist, with Mylanta II, an antacid, in the treatment of gastric ulcers. It's like choosing the right camel for a journey through the desert of digestive distress.

The researchers found that both treatments were effective in relieving symptoms of gastric ulcers, but cimetidine demonstrated significantly better results in promoting ulcer healing. This finding suggests that cimetidine may be a more effective choice for patients seeking long-term resolution of their gastric ulcer.

Cimetidine Shows Promise for Gastric Ulcer Healing

This study underscores the importance of choosing the right treatment approach for gastric ulcers, highlighting the potential of cimetidine as a more effective option for promoting ulcer healing. It's like selecting the camel best equipped to traverse the challenging landscape of digestive health.

Keeping Your Digestive System Healthy

This study emphasizes the importance of seeking professional medical guidance if you experience persistent digestive issues. It's like ensuring that your caravan has a skilled guide to navigate the complex terrain of digestive health. Remember, a healthy digestive system is crucial for overall well-being, allowing us to enjoy life's journey with greater comfort and ease.

Dr.Camel's Conclusion

This study reminds us that the journey through digestive health can be challenging, requiring the right tools and guidance to find relief and healing. While both cimetidine and Mylanta II can be effective in relieving symptoms, cimetidine shows greater promise in promoting long-term ulcer healing. It's essential to choose the treatment that best suits your individual needs and to consult with a healthcare professional for personalized care.

Date :
  1. Date Completed 1985-09-12
  2. Date Revised 2019-08-17
Further Info :

Pubmed ID

3894494

DOI: Digital Object Identifier

10.1097/00004836-198506000-00006

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.